Search results
Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Cevira...
WTNH-TV New Haven· 3 hours agoPhotocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris...
Cathie Wood Is Buying This Under-the-Radar AI Stock
Motley Fool via Yahoo Finance· 51 minutes agoThe 10 stocks that made the cut could produce monster returns in the coming years. Consider when Nvidia made this list on April 15, 2005... if you...
A Once-in-a-Decade Opportunity: 3 Magnificent Dividend Stocks Down Between 19% and 28% to Buy Now...
Motley Fool via Yahoo Finance· 6 hours agoThis outperformance potential, paired with the company's growing dividend that yields 1.5% and only...
How sham patents are hurting the pharma industry
Pharmaceutical Technology via Yahoo Finance· 5 days ago“The purpose of the Orange Book process,” says Rohit Singla...and then face patent litigation,” he adds. “If they lost, the generic faces potentially...
Merck and other pharma giants are bracing for competition to their blockbuster drugs. Here's how.
Quartz· 4 days agoEvery pharmaceutical company is constantly searching for its next blockbuster — the billion-dollar ...
The FTC is challenging 'junk' drug patents. Here's what they are and why they matter
Quartz· 4 days agoThe U.S. Federal Trade Commission (FTC) announced last week that it is, for the second time,...
Drug shortages: What to do when you can’t get your medicine
Deseret News via Yahoo News· 2 days ago“These are drugs we’ve used forever.” But what causes shortages? And more to the point, what do you...
East Bay biotech raises $105 million, aims to enter clinical trials with eczema drug - San Francisco...
The Business Journals· 2 days agoA young Fremont biotech company raised $105 million in a Series B round to propel drugs from its experimental approach to immune-mediated diseases into clinical trials. Attovia ...
Pfizer Is Adding a Wall Street Analyst to Its C-Suite. What He Thinks the Company Needs to Do.
Barrons.com· 6 days agoBut we have an idea of what he thinks the company needs to do. Baum has committed his thoughts about...
The Biden Administration Plans to Reschedule Marijuana: 3 Things You Need to Know Before Rushing to...
Motley Fool via Yahoo Finance· 22 hours agoThe 10 stocks that made the cut could produce monster returns in the coming years. Consider when...